Accelerating clinical research, on earth and beyond
TrialX (trialx.com) earns a Brand Analyzer score of 78 out of 100, placing it in the Brand-Ready tier among Healthcare brands, SaaS brands, Technology brands. Among 3422 Healthcare brands analyzed, TrialX ranks in the 75th percentile (category average 72, leader 96). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 100/100, Digital Presence 100/100, Visual Identity 90/100, Messaging Clarity 95/100, Trust Foundation 77/100, AI Discoverability 61/100, Brand Authority 37/100.
TrialX is a clinical research and space health technology company based in New York City. It provides a suite of digital tools for clinical trial recruitment and management, including the Dory clinical trial finder, the iConnect patient recruitment management system, an ePRO/eConsent platform, and the CureTalks online talk show. TrialX serves clinical trial sponsors, research sites, and patients, aiming to modernize and centralize trial awareness, recruitment, and participation processes.
| Brand Name | TrialX |
|---|---|
| Domain | trialx.com |
| Industry | Healthcare, SaaS |
| Headquarters | New York City |
| Main Competitors | Antidote Technologies (81/100), TrialSpark (75/100), Medidata Solutions (89/100), Medable (86/100), Signant Health (80/100), Clara Health (61/100) |
Moz Domain Authority 56/100 vs category average 35 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #334,874 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "TrialX is a clinical research and space health technology company headquartered in New York City. TrialX products include an award-winning clinical trial finder (Dory), a patient r…" (Meta description: 39 words. OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:type, Twitter cards. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Apache, WordPress, Webflow.
Social footprint: verified profiles on X (Twitter), LinkedIn, Instagram, GitHub; no detected presence on Facebook, YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
TrialX scores 31/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
TrialX has a weak AI-visibility profile at 31/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (55/100) and its weakest is visibility (18/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #334,874 (Tranco) and a Moz Domain Authority of 56/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify TrialX from memory (August 2026) - a sign these signals are paying off.
Live results from asking a general-purpose AI assistant about the brand, checked August 2026.
When asked "What is TrialX?", Claude could identify the brand as of August 2026. TrialX is a healthcare technology company that has worked on matching patients to clinical trials, using algorithms to connect patient health data with relevant trial eligibility criteria. Best known for Clinical trial matching technology for patients.
When asked "Best brands similar to TrialX?", Claude would not surface TrialX as of August 2026. It's a niche player in clinical trial matching and not one of the more prominent or widely recognized names I'd default to in that space.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
TrialX's main competitors include Antidote Technologies (81/100), TrialSpark (75/100), Medidata Solutions (89/100), Medable, Signant Health (80/100). These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Brand Analyzer scan
TrialX and Medidata Solutions are competitors in Healthcare. Brand Analyzer scores TrialX at 78/100 and Medidata Solutions at 89/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Brand Analyzer scan
Popular alternatives to TrialX include Antidote Technologies (81/100), TrialSpark (75/100), Medidata Solutions (89/100), Medable, Signant Health (80/100). Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Brand Analyzer scan
TrialX offers several products: Dory, a clinical trial finder that helps patients locate relevant trials; iConnect, a patient recruitment management system for sponsors and sites; an ePRO/eConsent platform for electronic patient-reported outcomes and informed consent; and CureTalks, an online talk show related to clinical research topics.
Sources: TrialX official site
TrialX has limited AI-search visibility, scoring 31/100 on Brand Analyzer's AI visibility composite (visibility 18, trust 29, recommendation 55). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: TrialX official site
TrialX scores 55/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: TrialX official site
TrialX is a clinical research and space health technology company headquartered in New York City. It develops digital tools designed to improve clinical trial awareness, recruitment, and participation for trial sponsors and research sites globally.
Sources: TrialX official site
TrialX builds and operates a suite of clinical trial technology products. This includes Dory, a clinical trial finder; iConnect, a patient recruitment management system; an ePRO/eConsent platform for electronic patient-reported outcomes and consent; and CureTalks, an online talk show. Together these tools help sponsors and sites manage trial listings, recruit patients, and engage participants throughout the clinical trial process.
Sources: TrialX official site
TrialX can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: TrialX official site
TrialX's tools are used by clinical trial sponsors, research sites, and patients seeking clinical trial information and participation. Sponsors and sites use its recruitment management and ePRO/eConsent tools to manage trial operations, while patients use tools like Dory to find and engage with relevant clinical trials.
Sources: TrialX official site
TrialX is known for its clinical trial finder tool called Dory, which has received industry recognition, as well as its integrated suite of recruitment and engagement tools for clinical trials, including iConnect and an ePRO/eConsent platform.
Sources: TrialX official site
Ranked closest to TrialX: Trella Health (78/100), Treatspace (78/100), Triglav osiguranje d.d. (78/100), Unified Smiles (78/100).
A step up - brands to learn from: Zurich Insurance Group (81/100), Zimmer Biomet (81/100).
Category leader: Elsevier (96/100).